$ARWR 3 SEC Filings

Filed On	Filing
17 Jun 2026	Form 3: Cohen Matthew Gregory, Director Holds 0 shares of Common Stock
12 Aug 2025	Form 3: Apel Daniel Joseph, Chief Financial Officer Holds 101,200 shares of Common Stock
07 Feb 2025	Form 3: Ingram Douglas S, Director Holds 0 shares of Common Stock
18 Mar 2024	Form 3: Lu Hongbo, Director Holds 30,680 shares of Common Stock
29 Jun 2022	Form 3: Oliver Tracie, Chief Commercial Officer Holds 70,000 shares of Common Stock
05 May 2022	Form 3: Vakiener Victoria, Director Holds 17,181 shares of Common Stock
02 Nov 2020	Form 3: Hamilton James C, Senior Vice President Holds 125,000 shares of Common Stock
08 Sep 2020	Form 3: Olukotun Adeoye Y, Director Holds 5,000 shares of Common Stock
13 Jan 2020	Form 3: Hassard James, Chief Commercial Officer Holds 125,000 shares of Common Stock
27 Dec 2019	Form 3: De Backer Marianne, Director Holds 5,000 shares of Common Stock
20 Nov 2019	Form 3: Bradshaw Curt, Chief Scientific Officer Holds 125,000 shares of Common Stock
20 Nov 2019	Form 3: San Martin Javier, Chief Medical Officer Holds 150,000 shares of Common Stock
29 Jan 2018	Form 3: Li Zhen, Snr. VP, Chemistry and Mfg Holds 167,200 shares of Common Stock
27 Dec 2017	Form 3: Waddill William D., Director No securities owned
10 Mar 2015	Form 3: Leone Peter Brian, VP, Strategy & Program Mgmt
04 Dec 2014	Form 3: O'Brien Patrick, General Counsel Holds 0 shares of No securities beneficially owned.
06 Jan 2014	Form 3: Lewis David L., Chief Scientific Officer
21 Feb 2012	Form 3: Given Douglas B, Director
06 Jan 2012	Form 3: Perry Michael S, Director
07 Nov 2011	Form 3: Given Bruce D, Chief Operating Officer

Comments